When proton pump inhibitors fail in gastroesophageal reflux disease: a narrative review of overlapping esophageal disorders of gut-brain interaction
Year: 2026
Type: review
Abstract: Background and Objective: Up to 40% of patients with gastroesophageal reflux disease (GERD) report persistent symptoms despite proton pump inhibitor (PPI) therapy. Historically, refractory symptoms were attributed primarily to residual acid or non-acid reflux. However, contemporary evidence demonstrates that overlapping esophageal disorders of gut-brain interaction (EDGBIs), particularly reflux hypersensitivity and functional heartburn, represent major mechanisms underlying persistent symptoms despite adequate acid suppression. This review aims to summarize current evidence regarding the overlap between GERD and EDGBIs and discuss contemporary diagnostic and therapeutic approaches for PPI-refractory symptoms.Methods: PubMed/MEDLINE was searched for relevant English-language studies published through March 2026, including clinical guidelines, randomized controlled trials, observational studies, and review articles addressing refractory GERD, esophageal hypersensitivity, reflux hypersensitivity, functional heartburn, ambulatory reflux monitoring, neuromodulators, and behavioral therapy. Findings were synthesized narratively with preference given to prospective studies, randomized controlled trials, and contemporary consensus statements.Key Content and Findings: Emerging evidence demonstrates that most patients with persistent reflux symptoms despite optimized PPI therapy do not have ongoing abnormal esophageal acid exposure. Instead, many exhibit overlapping EDGBIs driven by altered esophageal sensory processing and esophageal hypersensitivity. Rome IV criteria and modern ambulatory pH-impedance testing have reshaped the understanding of refractory GERD by identifying overlap phenotypes involving functional heartburn and reflux hypersensitivity. Recognition of these overlap syndromes has important therapeutic implications, shifting management away from escalating acid suppression toward neuromodulators, behavioral interventions, dietary modification, and multidisciplinary care.Conclusions: Refractory GERD frequently reflects overlap between confirmed GERD and EDGBIs rather than persistent pathologic reflux alone. Recognition of esophageal hypersensitivity and overlap phenotypes is essential for appropriate diagnosis, individualized management, and avoidance of unnecessary therapeutic escalation. Future research should focus on development of reliable clinical predictors of esophageal hypersensitivity and adequately powered trials of neuromodulatory and behavioral interventions in patients with confirmed GERD-EDGBI overlap.
Source: Annals of Esophagus
Authors: Amit Syal, Ofer Z. Fass
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7214673616
